Preventing abuse in guardianship focus of proposed bill, final rule
By
Kimberly Bonvissuto
May 09, 2024
Proposed legislation aims to reduce the potential for abuse of older adults and people with disabilities by creating public awareness about alternatives to guardianship, whereas a new federal final rule...
Fight against joint employer rule sees ‘significant procedural win’
By
Lois A. Bowers
Jun 13, 2024
A plaintiff in a lawsuit against the National Labor Relations Board over its joint employer rule is calling a recent court ruling a “significant procedural win.”
FDA approves new antibiotic for uncomplicated urinary tract tnfections
Apr 30, 2024
Approval of Pivya is for female adults with UTIs caused by susceptible isolates of E. coli, P. mirabilis,and S. saprophyticus.
Mease Life affiliates with Acts Retirement–Life Communities
By
Kathleen Steele Gaivin
Oct 04, 2023
Continuing care retirement community Mease Life of Dunedin, FL, and Fort Washington, PA-based Acts Retirement-Life Communities have finalized their affiliation after signing a letter of intent in April...
Healthcare orgs taking steps to remove racial bias from algorithm and AI tools, new report shows
By
Aaron Dorman
Jan 22, 2024
A team of doctors is going through algorithms to find, and remove, anything that could exacerbate racial bias, a new report shows.
Use of CT angiogram on the rise for headache, dizziness in emergency department
Apr 17, 2024
There was a 67.4% increase in head and neck computed tomography angiography ordering for emergency department patients from 2017 to 2021.
FDA approves first prescription digital therapy for major depression
Apr 04, 2024
The adjunctive treatment, delivered via smartphone app, reduces depression symptoms in participants on antidepressant medication.
Few cancer survivors fully adherent to ACS nutrition and physical activity guidelines
Apr 23, 2024
Factors associated with greater adherence include female sex, older age, Black race and higher educational level.
FDA approves Rezdiffra for nonalcoholic steatohepatitis
Mar 15, 2024
Drug was approved on an ‘accelerated’ schedule due to pressing medical need
FDA approves Aurlumyn for severe frostbite
Feb 15, 2024
The newly approved medication lowers the need for amputation of fingers or toes.